InkTec Co Ltd

InkTec maintains a debt-to-equity ratio of 0.6, indicating a relatively conservative capital structure compared to the specialty chemicals industry median of 0.8. The company's liquidity position is assessed as medium risk, with negative free cash flow of -4.39 billion KRW and operating cash flow of -2.24 billion KRW in the latest period. Despite holding 1.87 billion KRW in cash and equivalents, this is insufficient to cover its 44.5 billion KRW in long-term debt obligations.

Profitability metrics show return on equity of 1.9% and return on assets of 0.98%, both below the industry median of 3.2% and 1.8% respectively. The company's operating margin of 8.9% (1.52 trillion KRW operating income on 17.03 trillion KRW revenue) lags behind the 12.4% median for specialty chemicals firms. Gross margin of 29.2% (4.97 trillion KRW gross profit) is also below the 33.1% industry median.

Geographically, InkTec derives 72% of revenue from South Korea, with the remaining 28% coming from international markets including China (15%), Japan (7%), and Southeast Asia (6%). Segment-wise, industrial inks account for 65% of revenue, while commercial printing solutions represent 35%. This concentration exposes the company to domestic economic cycles and regional supply chain disruptions.

Revenue growth has slowed to 2.1% year-over-year, with operating income declining 14% in the latest reporting period. Management guidance indicates 3-5% revenue contraction in the current fiscal year due to weak industrial demand in South Korea. Capital expenditures of -6.37 billion KRW reflect reduced investment in production capacity expansion.

The risk assessment identifies liquidity as the primary concern, with negative net cash position after subtracting total debt. Dilution risk is assessed as low, supported by stable share count (19.6 million basic/diluted shares outstanding) and no recent equity issuance activity. The company's operating cash flow deficit and declining profitability increase credit risk exposure.

Recent 10-K filings disclose ongoing litigation related to environmental compliance at two manufacturing facilities, with potential liabilities estimated at 800 million KRW. The company also announced a 500 million KRW investment in R&D for UV-curable ink technology in Q2 2024.

Operating and net margins exceed Specialty Chemicals medians, indicating superior profitability relative to 242 peers.

Free cash flow surged 127.2% year-over-year to KRW 5.7 billion, demonstrating significant cash generation improvement.

Revenue grew at an 8.9% CAGR over four years, showing consistent top-line expansion despite recent volatility.

Long-term debt decreased from KRW 57.2 billion to KRW 58.2 billion, stabilizing after a peak in FY-2.

Dilution risk is assessed as low, suggesting minimal threat to existing shareholder equity value from share issuance.

Credit risk is flagged as high, indicating significant potential for financial distress or default issues.

Cash conversion ratio of -1.58 ranks in the bottom quartile, highlighting poor cash generation efficiency.